Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Sales | 2,742 | 2,654 | 2,370 | -681 | 2,311 |
| Gross Profit | 2,742 | 2,654 | 2,370 | -681 | 2,311 |
| Operating Expenses | 9,544 | 8,482 | 6,518 | 7,223 | 5,341 |
| Operating Income | -6,803 | -5,828 | -4,148 | -7,904 | -3,030 |
| Interest Expense | 0 | 5 | 0 | 13 | 12 |
| Other Income | 390 | 473 | 2,147 | 3,348 | 0 |
| Pre-tax Income | -6,412 | -5,360 | -2,001 | -4,568 | -3,042 |
| Net Income Continuous | -6,412 | -5,360 | -2,001 | -4,568 | -3,042 |
| Net Income | $-6,412 | $-5,360 | $-2,001 | $-4,568 | $-3,042 |
| EPS Basic Total Ops | -0.51 | -0.43 | -0.16 | -0.36 | -0.25 |
| EPS Basic Continuous Ops | -0.51 | -0.43 | -0.16 | -0.37 | -0.25 |
| EPS Diluted Total Ops | -0.51 | -0.43 | -0.16 | -0.31 | -0.25 |
| EPS Diluted Continuous Ops | -0.51 | -0.43 | -0.16 | -0.32 | -0.25 |
| EBITDA(a) | $-6,193 | $-5,267 | $-3,653 | $-7,523 | $-2,734 |